HOME >> MEDICINE >> NEWS
New class of HIV drug attacks previously untargeted enzyme

A new class of anti-HIV drug which inhibits an as-yet untargeted enzyme in the virus has proven effective in a drug trial, according to an Article in this weeks edition of The Lancet.

There is an urgent need for new antiretroviral drugs due to existing rates of failure in existing combination antiretroviral therapies. The current study looked at the new "integrase-inhibitor" raltegravir when used in conjunction with optimised background combination therapies, in patients with advanced HIV infection whose existing treatments were failing.

There are three types of enzyme essential to the successful replication of HIV reverse-transcriptase, protease and integrase. Integrase is responsible for insertion of HIV DNA into the host cells DNA. Until now all antiretroviral drugs for HIV which target enzymes have been reverse-transcriptase or protease inhibitors.

Dr Bach-Yen Nguyen, Merck Research Laboratories, Westpoint, Pennsylvania, USA, and colleagues divided their patients into four groups. One group received the background treatment plus placebo only, and the other three received the background treatment plus 200, 400 or 600mg of raltegravir twice daily. All 178 patients across the four groups had been receiving antiretroviral therapy for an average of just under 10 years.

The researchers measured the amount of HIV genetic material (HIV RNA) in the blood of patients after 24 weeks, and found that patients taking raltegravir experienced an average of 98% drop in their HIV RNA count, compared to just 45% drop in the placebo group.

The number of CD4 cells which give an indication of the immune response were also significantly boosted in patients taking raltegravir. Patients receiving the 400mg and 600mg doses increased their CD4 count by 113 and 94 cells per ml of blood respectively.

Raltegravir also proved safe, well tolerated and potent in most of the patients.

In related studies of raltegravir*,
'"/>

Contact: Bach-Yen Nguyen
bachyen_nguyen@merck.com
267-305-7278
Lancet
12-Apr-2007


Page: 1 2

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. Early-morning Friday classes may prevent students from getting sloppy on thirsty Thursdays
3. Panel offers guidelines on skin reactions to new class of cancer drugs
4. UK researchers find new class of nontoxic cancer treatments
5. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
6. Sleep disturbances affect classroom performance
7. Simple classification can help define and predict limb-threatening diabetic infections
8. World-class Biomedical Research Center to be in West London
9. A new way of classifying addictive drugs
10. Phys ed class more effective when theres more talking
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: